Repeated loco-regional therapies for hepatocellular carcinoma is associated with inferior outcome after living donor liver transplantation in cirrhotic patients

被引:3
|
作者
Tsou, Yi-Fan [1 ]
Lin, Niang-Cheng [1 ]
Hsia, Cheng-Yuan [1 ,2 ]
Loong, Che-Chuan [1 ,2 ]
Tsai, Hsin-Lin [1 ,3 ]
Chen, Cheng-Yen [1 ]
Lei, Hao-Jan [1 ,2 ]
Chou, Shu-Cheng [1 ,2 ]
Chung, Meng-Hsuan [1 ]
Kuo, Fang-Cheng [1 ]
Liu, Chin-Su [1 ,3 ]
机构
[1] Taipei Vet Gen Hosp, Dept Surg, Div Transplantat Surg, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Surg, Div Pediat Surg, Taipei, Taiwan
关键词
Hepatocellular carcinoma; Liver transplantation; Living donor liver transplantation; Loco-regional therapy; Outcomes; CHEMOEMBOLIZATION; IMPACT;
D O I
10.1097/JCMA.0000000000000670
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Liver transplantation is the definitive treatment for defined stage hepatocellular carcinoma (HCC) in cirrhotic patients. Loco-regional therapy (LRT) may be considered before transplantation to prevent the disease progression and the patient from dropping out of the waiting list. This study aims to evaluate the impact of repeated pretransplant LRTs on the long-term outcomes in HCC liver transplant recipients. Methods: Between 2004 and 2019, living donor liver transplantation (LDLT) recipients with viable HCC on the explant livers were enrolled. Uni- and multivariate analysis was performed with the Cox regression model to stratify the risk factors associated with HCC recurrence and patent survival after LDLT. Results: A total of 124 patients were enrolled, in which 65.3% (n = 81) were Barcelona Clinic Liver Cancer classification stage B or D and 89% (n = 110) had advanced fibrosis or cirrhosis on the explanted livers. After a median follow-up of 41 months (IQR: 24-86.5), there were 18 cases (13.7%) of HCC recurrence. Univariate analysis showed that the model of end-stage liver disease and Child-Turcotte-Pugh score, pretransplant alpha-fetoprotein value (>500 ng/ml), repeated pretransplant LRTs (N > 4), increased tumor numbers and maximal size, presence of microvascular invasion, and the histological grading of the tumors are risk factors of inferior outcomes. In multivariate analysis, only repeated pretransplant LRTs (N > 4) had a significant impact on both the overall- and recurrence-free survival. The impact of pretransplant LRT was consistently significant among subgroups based on their LRT episodes (N = 0, 1-4, >4 respectively). Conclusion: Repeated LRT for HCC can be associated with the risk of tumor recurrence and inferior patient survival after LDLT in cirrhotic patients. Early referral of those eligible for transplantation may improve the treatment outcomes in these patients.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 50 条
  • [41] Outcome of cirrhotic patients with incidental hepatocellular carcinoma undergoing liver transplantation
    Charco, R
    Hidalgo, E
    Lázaro, JL
    Vargas, V
    Castells, L
    Murio, E
    Bilbao, I
    Margarit, C
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 299 - +
  • [42] Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Saidi, R. F.
    Jabbour, N.
    Li, Y.
    Shah, S.
    Bozorgzadeh, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 37 - 37
  • [43] LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
    Luo, Ying
    HEPATOLOGY, 2011, 54 : 677A - 677A
  • [44] Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Nabi, Prithiviraj
    Rammohan, Ashwin
    Rela, Mohamed
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (06)
  • [45] Living donor liver transplantation for hepatocellular carcinoma
    Nakatsuka, H
    Sato, Y
    Yamamoto, S
    Hatakeyama, K
    LIVER TRANSPLANTATION, 2004, 10 (06) : C28 - C28
  • [46] Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Isik, B.
    Ince, V.
    Karabulut, K.
    Kayaalp, C.
    Yilmaz, S.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (06) : 1713 - 1716
  • [47] Living donor liver transplantation for hepatocellular carcinoma
    Kulik, L
    Abecassis, M
    GASTROENTEROLOGY, 2004, 127 (05) : S277 - S282
  • [48] Impact of the degree of tumor necrosis after pre-operative loco-regional treatments on outcome following liver transplantation for hepatocellular carcinoima
    Yao, FY
    Ferrell, LD
    Li, X
    Darbonne, D
    Bass, NM
    Hirose, R
    Kerlan, RK
    Ascher, NL
    Roberts, JP
    GASTROENTEROLOGY, 2004, 126 (04) : A677 - A677
  • [49] Clinical Analysis of Patients with Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
    Na, Gun Hyung
    Choi, Sung Ho
    Hong, Tae Ho
    You, Young Kyoung
    Kim, Dong Goo
    TRANSPLANTATION, 2016, 100 : S234 - S234
  • [50] Change in Alpha-fetoprotein after Loco-Regional Therapy as Predictor of Recurrence after Liver Transplantation for Hepatocellular Carcinoma: A Multicenter European Study
    Lai, Q.
    Graziadei, I
    Ciccarelli, O.
    Berloco, P. B.
    Manzia, T. M.
    Avolio, A. W.
    Agnes, S.
    Tisone, G.
    Rossi, M.
    Vogel, W.
    Lerut, J.
    TRANSPLANTATION, 2012, 94 (10) : 253 - 253